{"id":63,"date":"2026-05-08T19:15:10","date_gmt":"2026-05-08T10:15:10","guid":{"rendered":"https:\/\/home.hirosaki-u.ac.jp\/pharmacy\/?page_id=63"},"modified":"2026-06-30T19:46:52","modified_gmt":"2026-06-30T10:46:52","slug":"page-63","status":"publish","type":"page","link":"https:\/\/home.hirosaki-u.ac.jp\/pharmacy\/page-63\/","title":{"rendered":"2025\u5e74\u5ea6\u3000\u7814\u7a76\u30fb\u6210\u679c"},"content":{"rendered":"

2025\u5e74\u5ea6<\/h2>\n

\u539f\u8457\u8ad6\u6587<\/h4>\n
    \n
  1. Nakagawa J, Ishido K, Kimura N, Nagase H, Wakasa Y, Yokoyama S, Ueno K, Hakamada K, Niioka T. Abnormally high plasma concentrations of M-4, the active metabolite of edoxaban, at the onset of acute kidney injury in a patient receiving rifampin and clarithromycin: a case report. J Pharm Health Care Sci. 2024 Oct 28; 10(1):66. doi: 10.1186\/s40780-024-00390-6.<\/li>\n
  2. Satoshi Y, Junichi N, Michiko S, Kayo U, Masahiro I, Norio N, Hirofumi T, Takenori N. Quantification of the Plasma Concentration of Vadadustat by High-Performance Liquid Chromatography with Ultraviolet Detection and Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry. Ther Drug Monit. 2024 Dec; 46(6): 813-819. doi: 10.1097\/FTD.0000000000001238. Epub 2024 Jul 2.<\/li>\n
  3. \u5ca1\u6751\u7950\u55e3, \u6771\u91ce\u512a\u82b1, \u6d25\u5c71\u535a\u5321, \u9577\u7530\u5927, \u67ff\u5d0e\u548c\u4e5f, \u99ac\u5834\u5553\u8cb4, \u5ca1\u5d0e\u572d\u4f51, \u963f\u90e8\u8b72, \u5965\u5c71\u52dd\u4fca, \u5357\u548c\u5fd7, \u5c0f\u6797\u85ab, \u82b1\u7530\u548c\u5927, \u67f3\u5ddd\u660e\u5b50, \u9ad8\u6a4b\u5343\u9db4, \u7530\u6751\u5065\u60a6, \u9f4b\u85e4\u7d00\u5148, \u65b0\u5ca1\u4e08\u5178: \u30e1\u30ed\u30da\u30cd\u30e0\u6c34\u548c\u7269\u306eProspective Audit and Feedback\u5b9f\u65bd\u624b\u9806\u66f8\u306e\u65bd\u8a2d\u9593\u5171\u6709\u304c\u4f7f\u7528\u671f\u9593\u306b\u53ca\u307c\u3059\u5f71\u97ff. \u65e5\u672c\u75c5\u9662\u85ac\u5264\u5e2b\u4f1a\u96d1\u8a8c 2024; 60:871-875<\/li>\n<\/ol>\n

    \u5b66\u4f1a\u767a\u8868<\/h4>\n
      \n
    1. \u5ddd\u53e3\u8056\u4e5f, \u5de5\u85e4\u6b63\u7d14, \u91d1\u6fa4\u4f50\u77e5\u5b50, \u5c0f\u539f\u4fe1\u4e00, \u4e2d\u5ddd\u6f64\u4e00, \u6d25\u5c71\u535a\u5321, \u963f\u4fdd\u6210\u6176, \u76f8\u5185\u5c1a\u4e5f, \u4e16\u6c38\u65e9\u7d00, \u4eca\u826f\u4ec1, \u4f0a\u85e4\u68a2, \u9f4b\u85e4\u572d\u609f, \u867b\u5ddd\u90c1, \u6a2a\u5c71\u667a\u58eb, \u65b0\u5ca1\u4e08\u5178: Z\u4e16\u4ee3\u306e\u793e\u4f1a\u4eba\u53ca\u3073\u85ac\u5b66\u751f\u3092\u5bfe\u8c61\u3068\u3057\u305fDX\u30d5\u30a1\u30fc\u30de\u30b7\u30e5\u30fc\u30c6\u30a3\u30ab\u30eb\u30b1\u30a2\u3078\u306e\u79fb\u884c\u306b\u5411\u3051\u305f\u610f\u8b58\u8abf\u67fb, \u65e5\u672c\u793e\u4f1a\u85ac\u5b66\u4f1a \u7b2c42\u56de \u5e74\u4f1a\uff08\u798f\u5ca1\uff09, 2024.6.<\/li>\n
    2. \u6a2a\u5c71\u667a\u58eb:\u30b7\u30c3\u30af\u30c7\u30a4\u306b\u304a\u3051\u308b\u85ac\u7269\u6cbb\u7642\u30e2\u30cb\u30bf\u30ea\u30f3\u30b0\uff08\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff09, \u7b2c78\u56de\u533b\u85ac\u54c1\u76f8\u4e92\u4f5c\u7528\u7814\u7a76\u4f1a\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff08\u9752\u68ee\uff09, 2024.6.<\/li>\n
    3. \u76f8\u5185\u5c1a\u4e5f: \u708e\u75c7\u53cd\u5fdc\u306e\u7a0b\u5ea6\u306b\u3088\u3063\u3066\u6297\u771f\u83cc\u85ac\u30dc\u30ea\u30b3\u30ca\u30be\u30fc\u30eb\u4ee3\u8b1d\u6d3b\u6027\u304c\u7d4c\u6642\u7684\u306b\u5909\u5316\u3057\u305f\u75c7\u4f8b\uff08\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff09, \u65e5\u672c\u75c5\u9662\u85ac\u5264\u5e2b\u4f1a\u6771\u5317\u30d6\u30ed\u30c3\u30af\u7b2c13\u56de\u5b66\u8853\u5927\u4f1a\uff08\u9752\u68ee\uff09, 2024.6.<\/li>\n
    4. \u867b\u5ddd\u90c1, \u5de5\u85e4\u6b63\u7d14, \u91d1\u6fa4\u4f50\u77e5\u5b50, \u5c0f\u539f\u4fe1\u4e00, \u4e2d\u5ddd\u6f64\u4e00, \u6d25\u5c71\u535a\u5321, \u963f\u4fdd\u6210\u6176, \u76f8\u5185\u5c1a\u4e5f, \u4e16\u6c38\u65e9\u7d00, \u4eca\u826f\u4ec1, \u5ddd\u53e3\u8056\u4e5f, \u4f0a\u85e4\u68a2, \u9f4b\u85e4\u572d\u609f, \u6a2a\u5c71\u667a\u58eb, \u65b0\u5ca1\u4e08\u5178: \u793e\u4f1a\u4eba\u53ca\u3073\u85ac\u5b66\u751f\u3092\u5bfe\u8c61\u3068\u3057\u305f\u30aa\u30f3\u30e9\u30a4\u30f3\u670d\u85ac\u6307\u5c0e\u306b\u95a2\u3059\u308b\u5229\u7528\u610f\u5411\u8abf\u67fb, \u65e5\u672c\u75c5\u9662\u85ac\u5264\u5e2b\u4f1a\u6771\u5317\u30d6\u30ed\u30c3\u30af\u7b2c13\u56de\u5b66\u8853\u5927\u4f1a\uff08\u9752\u68ee\uff09, 2024.6.<\/li>\n
    5. \u4eca\u826f\u4ec1, \u4e2d\u5ddd\u6f64\u4e00, \u65b0\u5ca1\u4e08\u5178: \u70ad\u9178\u30ea\u30c1\u30a6\u30e0\u306e\u9069\u6b63\u4f7f\u7528\u652f\u63f4\u306b\u304a\u3051\u308b\u7cbe\u795e\u79d1\u75c5\u68df\u62c5\u5f53\u85ac\u5264\u5e2b\u306b\u3088\u308b\u8840\u4e2d\u6fc3\u5ea6\u30e2\u30cb\u30bf\u30ea\u30f3\u30b0\u63a8\u9032\u306b\u95a2\u3059\u308b\u53d6\u308a\u7d44\u307f, \u65e5\u672c\u75c5\u9662\u85ac\u5264\u5e2b\u4f1a\u6771\u5317\u30d6\u30ed\u30c3\u30af\u7b2c13\u56de\u5b66\u8853\u5927\u4f1a\uff08\u9752\u68ee\uff09, 2024.6.<\/li>\n
    6. \u7551\u5c71\u6602\u5927, \u7167\u4e95\u4e00\u53f2, \u91d1\u6fa4\u4f50\u77e5\u5b50, \u65b0\u5ca1\u4e08\u5178: \u6ce8\u5c04\u7528 K \u88fd\u5264\u6fc3\u5ea6\u306b\u95a2\u3059\u308b\u9662\u5185\u898f\u5b9a\u7b56\u5b9a\u306b\u3088\u308b\u7591\u7fa9\u7167\u4f1a\u52d5\u5411\u306e\u5909\u5316, \u65e5\u672c\u75c5\u9662\u85ac\u5264\u5e2b\u4f1a\u6771\u5317\u30d6\u30ed\u30c3\u30af\u7b2c13\u56de\u5b66\u8853\u5927\u4f1a\uff08\u9752\u68ee\uff09, 2024.6.<\/li>\n
    7. \u4e2d\u5ddd\u6f64\u4e00, \u77f3\u6238\u572d\u4e4b\u8f14, \u6728\u6751\u61b2\u592e, \u9577\u702c\u52c7\u4eba, \u82e5\u72ed\u60a0\u4ecb, \u6a2a\u5c71\u667a\u58eb, \u4e0a\u91ce\u6842\u4ee3, \u88b4\u7530\u5065\u4e00, \u65b0\u5ca1\u4e08\u5178: \u30a8\u30c9\u30ad\u30b5\u30d0\u30f3\u306e\u6d3b\u6027\u4ee3\u8b1d\u7269M-4\u304c\u7570\u5e38\u9ad8\u5024\u3092\u793a\u3057\u305f\u30af\u30e9\u30ea\u30b9\u30ed\u30de\u30a4\u30b7\u30f3\u53ca\u3073\u30ea\u30d5\u30a1\u30f3\u30d4\u30b7\u30f3\u4f75\u7528AKI\u75c7\u4f8b, \u7b2c7\u56de\u65e5\u672c\u81e8\u5e8a\u85ac\u7406\u5b66\u4f1a\u5317\u6d77\u9053\u30fb\u6771\u5317\u5730\u65b9\u4f1a\uff08\u5ca9\u624b\uff09, 2024.6.<\/li>\n
    8. \u9f4b\u85e4\u572d\u609f, \u4e2d\u5ddd\u6f64\u4e00, \u9ad8\u7551\u6b66\u529f, \u9673\u8c6b, \u9f4b\u85e4\u7d62\u4ecb, \u938c\u7530\u8015\u8f14, \u7acb\u7530\u5353\u767b, \u4e0a\u91ce\u6842\u4ee3, \u4f50\u85e4\u6e29, \u6afb\u5ead\u88d5\u4e08, \u65b0\u5ca1\u4e08\u5178: Limited sampling strategy\u306b\u3088\u308b\u30c9\u30ad\u30bd\u30eb\u30d3\u30b7\u30f3\u53ca\u3073\u30c9\u30ad\u30bd\u30eb\u30d3\u30b7\u30ce\u30fc\u30eb\u8840\u4e2d\u6fc3\u5ea6\u30fb\u6642\u9593\u9762\u7a4d\u66f2\u7dda\u4e0b\u4e88\u6e2c\u6cd5\u306e\u958b\u767a, \u7b2c40\u56de\u65e5\u672cTDM\u5b66\u4f1a\u30fb\u5b66\u8853\u5927\u4f1a\uff08\u5317\u6d77\u9053\uff09, 2024.7.<\/li>\n
    9. \u6a2a\u5c71\u667a\u58eb, \u5cf6\u7530\u7f8e\u667a\u5b50, \u4e2d\u5ddd\u6f64\u4e00, \u4e0a\u91ce\u6842\u4ee3, \u77f3\u5c71\u96c5\u5927, \u4e2d\u6751\u5178\u96c4, \u5bcc\u7530\u6cf0\u53f2, \u65b0\u5ca1\u4e08\u5178: \u30d0\u30c0\u30c7\u30e5\u30b9\u30bf\u30c3\u30c8\u306e\u85ac\u7269\u52d5\u614b\u306b\u53ca\u307c\u3059SLCO1B1\u907a\u4f1d\u5b50\u591a\u578b\u306e\u5f71\u97ff, \u7b2c18\u56de\u65e5\u672c\u814e\u81d3\u75c5\u85ac\u7269\u7642\u6cd5\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u30fb\u7dcf\u4f1a2024\uff08\u5317\u6d77\u9053\uff09, 2024.9.<\/li>\n
    10. \u4e2d\u5ddd\u6f64\u4e00, \u6d25\u5c71\u535a\u5321, \u4e0a\u91ce\u6842\u4ee3, \u4e09\u4e0a\u662d\u592b, \u77f3\u5c71\u96c5\u5927, \u5bcc\u7530\u6cf0\u53f2, \u65b0\u5ca1\u4e08\u5178: LM1010\u9ad8\u901f\u6db2\u4f53\u30af\u30ed\u30de\u30c8\u30b0\u30e9\u30d5\u306b\u3088\u308b\u30d0\u30f3\u30b3\u30de\u30a4\u30b7\u30f3\u53ca\u3073\u30ea\u30cd\u30be\u30ea\u30c9\u8840\u4e2d\u6fc3\u5ea6\u6e2c\u5b9a\u306e\u7cbe\u5ea6\u8a55\u4fa1, \u7b2c35\u56de\u65e5\u672c\u81e8\u5e8a\u5316\u5b66\u4f1a\u6771\u5317\u652f\u90e8\u7dcf\u4f1a\uff08\u79cb\u7530\uff09, 2024.9.<\/li>\n
    11. \u77f3\u5ca1\u7406\u83ef, \u897f\u6fa4\u4e09\u4fdd\u5b50, \u4e09\u6d66\u65e9\u82d7, \u7530\u4e2d\u88d5\u5b50, \u8c37\u5ddd\u539f\u307f\u3086\u304d, \u6d77\u8001\u540d\u9ebb\u7f8e, \u7af9\u6751\u611b\u9999, \u9593\u5c71\u304b\u308b\u306a, \u5de5\u85e4\u6b63\u7d14, \u65b0\u5ca1\u4e08\u5178: \u4f01\u696d\u6cbb\u9a13\u5b9f\u65bd\u6642\u306b\u304a\u3051\u308b\u691c\u67fb\u8a2d\u5099\u306e\u7cbe\u5ea6\u7ba1\u7406\u72b6\u6cc1\u30fb\u4fdd\u5b88\u70b9\u691c\u8a18\u9332\u60c5\u5831\u7ba1\u7406\u306b\u95a2\u3059\u308b\u7c21\u7d20\u5316\u306e\u53d6\u308a\u7d44\u307f, \u7b2c24\u56de CRC\u3068\u81e8\u5e8a\u8a66\u9a13\u306e\u3042\u308a\u65b9\u3092\u8003\u3048\u308b\u4f1a\u8b70 2024 in Sapporo\uff08\u5317\u6d77\u9053\uff09, 2024.9<\/li>\n
    12. \u7af9\u6751\u611b\u9999, \u897f\u6fa4\u4e09\u4fdd\u5b50, \u4e09\u6d66\u65e9\u82d7, \u7530\u4e2d\u88d5\u5b50, \u8c37\u5ddd\u539f\u307f\u3086\u304d, \u6d77\u8001\u540d\u9ebb\u7f8e, \u77f3\u5ca1\u7406\u83ef, \u9593\u5c71\u304b\u308b\u306a, \u5de5\u85e4\u6b63\u7d14, \u65b0\u5ca1\u4e08\u5178: \u539f\u8cc7\u6599\u7279\u5b9a\u30ea\u30b9\u30c8\u30fb\u30d7\u30ed\u30bb\u30b9\u78ba\u8a8d\u30b7\u30fc\u30c8\u4f5c\u6210\u306b\u3088\u308bCRC \u696d\u52d9\u52b9\u7387\u5316\u306e\u8a66\u307f, \u7b2c24\u56de CRC\u3068\u81e8\u5e8a\u8a66\u9a13\u306e\u3042\u308a\u65b9\u3092\u8003\u3048\u308b\u4f1a\u8b70 2024 in Sapporo\uff08\u5317\u6d77\u9053\uff09, 2024.9.<\/li>\n
    13. \u4e2d\u5ddd\u6f64\u4e00: \u9ad8\u9f62\u8005\u975e\u30db\u30b8\u30ad\u30f3\u30ea\u30f3\u30d1\u816b\u306e\u304c\u3093\u5316\u5b66\u7642\u6cd5\uff08\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff09, \u7b2c34\u56de\u533b\u7642\u85ac\u5b66\u4f1a\u5e74\u4f1a\uff08\u5343\u8449\uff09, 2024.11.<\/li>\n
    14. \u4e2d\u5ddd\u6f64\u4e00, \u77f3\u6238\u572d\u4e4b\u8f14, \u6728\u6751\u61b2\u592e, \u9577\u702c\u52c7\u4eba, \u82e5\u72ed\u60a0\u4ecb, \u76f8\u5185\u5c1a\u4e5f, \u6771\u91ce\u512a\u82b1, \u4e0a\u91ce\u6842\u4ee3, \u88b4\u7530\u5065\u4e00, \u65b0\u5ca1\u4e08\u5178: \u5468\u8853\u671f\u306e\u708e\u75c7\u53cd\u5fdc\u304cCYP2C19\u6d3b\u6027\u306e\u5909\u52d5\u306b\u53ca\u307c\u3059\u5f71\u97ff, \u7b2c34\u56de\u533b\u7642\u85ac\u5b66\u4f1a\u5e74\u4f1a\uff08\u5343\u8449\uff09, 2024.11.<\/li>\n
    15. \u7551\u5c71\u6602\u5927, \u85e4\u7530\u96c4, \u4e2d\u5ddd\u6f64\u4e00, \u77f3\u5c71\u96c5\u5927, \u6751\u4e0a\u793c\u4e00, \u5bcc\u7530\u6cf0\u53f2, \u65b0\u5ca1\u4e08\u5178: COVID-19 \u306b\u611f\u67d3\u3057\u305f\u814e\u79fb\u690d\u5f8c\u306e\u60a3\u8005\u306b\u304a\u3044\u3066\u3001\u30bf\u30af\u30ed\u30ea\u30e0\u30b9\u3068\u30cb\u30eb\u30de\u30c8\u30ec\u30eb\u30d3\u30eb\/\u30ea\u30c8\u30ca\u30d3\u30eb\u3092\u4f75\u7528\u3057\u305f\u75c7\u4f8b, \u7b2c34\u56de\u533b\u7642\u85ac\u5b66\u4f1a\u5e74\u4f1a\uff08\u5343\u8449\uff09, 2024.11.<\/li>\n
    16. \u4e2d\u5ddd\u6f64\u4e00: CYP2C19\u907a\u4f1d\u5b50\u591a\u578b\u306e\u500b\u5225\u5316\u6295\u4e0e\u8a2d\u8a08\u3078\u306e\u5fdc\u7528\uff08\u30b7\u30f3\u30dd\u30b8\u30a6\u30e0\uff09, \u7b2c45\u56de\u65e5\u672c\u81e8\u5e8a\u85ac\u7406\u5b66\u4f1a\u5b66\u8853\u7dcf\u4f1a\uff08\u57fc\u7389\uff09, 2024.12.<\/li>\n
    17. \u76f8\u5185\u5c1a\u4e5f, \u4e2d\u5ddd\u6f64\u4e00, \u5e02\u5ddd\u535a\u7ae0, \u4e0a\u91ce\u6842\u4ee3, \u5bcc\u7530\u6cf0\u53f2, \u65b0\u5ca1\u4e08\u5178: \u30b5\u30af\u30d3\u30c8\u30ea\u30eb\u304a\u3088\u3073\u6d3b\u6027\u4ee3\u8b1d\u7269sacubitrilat\u306e\u8840\u6f3f\u4e2d\u6fc3\u5ea6\u306b\u53ca\u307c\u3059\u60a3\u8005\u56e0\u5b50\u306e\u691c\u8a0e, \u65e5\u672c\u85ac\u5b66\u4f1a\u7b2c145\u5e74\u4f1a\uff08\u798f\u5ca1\uff09, 2025.3.<\/li>\n<\/ol>\n

      \u305d\u306e\u4ed6<\/h4>\n
        \n
      1. \u7167\u4e95\u4e00\u53f2: \u304c\u3093\u5316\u5b66\u7642\u6cd5\u3092\u5b89\u5168\u306b\u65bd\u884c\u3059\u308b\u305f\u3081\u306b, \u304c\u3093\u5316\u5b66\u7642\u6cd5\u526f\u4f5c\u7528\u30cf\u30f3\u30c9\u30d6\u30c3\u30af\u7b2c4\u7248, \u7f8a\u571f\u793e; 2024.2.<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"

        2025\u5e74\u5ea6 \u539f\u8457\u8ad6\u6587 Nakagawa J, Ishido K, Kimura N, Nagase H, Wakasa Y, Yokoyama S, Ueno K, Hakamada K, Niioka T. Abno […]<\/p>\n","protected":false},"author":162,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-63","page","type-page","status-publish","hentry"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/home.hirosaki-u.ac.jp\/pharmacy\/wp-json\/wp\/v2\/pages\/63","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/home.hirosaki-u.ac.jp\/pharmacy\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/home.hirosaki-u.ac.jp\/pharmacy\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/home.hirosaki-u.ac.jp\/pharmacy\/wp-json\/wp\/v2\/users\/162"}],"replies":[{"embeddable":true,"href":"https:\/\/home.hirosaki-u.ac.jp\/pharmacy\/wp-json\/wp\/v2\/comments?post=63"}],"version-history":[{"count":2,"href":"https:\/\/home.hirosaki-u.ac.jp\/pharmacy\/wp-json\/wp\/v2\/pages\/63\/revisions"}],"predecessor-version":[{"id":191,"href":"https:\/\/home.hirosaki-u.ac.jp\/pharmacy\/wp-json\/wp\/v2\/pages\/63\/revisions\/191"}],"wp:attachment":[{"href":"https:\/\/home.hirosaki-u.ac.jp\/pharmacy\/wp-json\/wp\/v2\/media?parent=63"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}